Showing results (361-370 of 447) with videos related to

Sort By:
Pageof 45
Journal of Thoracic Oncology : Official Publication of the International Association for the Study of Lung Cancer|June 20, 2024
Neoadjuvant and Adjuvant Treatments for Early Stage Resectable NSCLC: Consensus Recommendations From the International Association for the Study of Lung CancerJonathan D Spicer, Tina Cascone, Murry W Wynes, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|November 10, 2016
BRM Promoter Polymorphisms and Survival of Advanced Non-Small Cell Lung Cancer Patients in the Princess Margaret Cohort and CCTG BR.24 TrialGeoffrey Liu, Sinead Cuffe, Shermi Liang, et al.
The European Respiratory Journal|January 24, 2015
Plasma pro-surfactant protein B and lung function decline in smokersJanice M Leung, John Mayo, Wan Tan, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|July 1, 2015
Clinical Utility of Patient-Derived Xenografts to Determine Biomarkers of Prognosis and Map Resistance Pathways in EGFR-Mutant Lung AdenocarcinomaErin L Stewart, Celine Mascaux, Nhu-An Pham, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|January 30, 2020
Phase II Trial of Cabozantinib in Recurrent/Metastatic Endometrial Cancer: A Study of the Princess Margaret, Chicago, and California Consortia (NCI9322/PHL86)Neesha C Dhani, Hal W Hirte, Lisa Wang, et al.
Archives of Pathology & Laboratory Medicine|July 8, 2017
Immunohistochemistry of Pulmonary Biomarkers: A Perspective From Members of the Pulmonary Pathology SocietyErik Thunnissen, Timothy Craig Allen, Julien Adam, et al.
Nature Communications|November 2, 2021
The Q61H mutation decouples KRAS from upstream regulation and renders cancer cells resistant to SHP2 inhibitorsTeklab Gebregiworgis, Yoshihito Kano, Jonathan St-Germain, et al.
Journal of Thoracic Oncology : Official Publication of the International Association for the Study of Lung Cancer|July 2, 2019
Pathologic Considerations and Standardization in Mesothelioma Clinical TrialsMing-Sound Tsao, Michele Carbone, Francoise Galateau-Salle, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|November 8, 2024
Randomized Phase II Study of Durvalumab with or without Tremelimumab in Patients with Metastatic Castration-Resistant Prostate CancerEric Winquist, Sebastien J Hotte, Kim Chi, et al.
Modern Pathology : an Official Journal of the United States and Canadian Academy of Pathology, Inc|September 6, 2019
Localized malignant mesothelioma, an unusual and poorly characterized neoplasm of serosal origin: best current evidence from the literature and the International Mesothelioma PanelAlberto M Marchevsky, Andras Khoor, Ann E Walts, et al.
Pageof 45